These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 2139359)
41. [Combined effects of gamma rays, cis-diamminedichloroplatinum (CDDP) and systemic hyperthermia mastocytoma transplanted into muscle in the mouse]. Nakamura W; Komatsu K; Kageyama K C R Seances Soc Biol Fil; 1985; 179(4):558-62. PubMed ID: 2938683 [TBL] [Abstract][Full Text] [Related]
42. [Recent advances in hypoxic cell radiosensitizer]. Ono K; Takahashi M; Nishidai T; Shibamoto Y; Abe M Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470 [TBL] [Abstract][Full Text] [Related]
43. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling. Baba H; Siddik ZH; Strebel FR; Jenkins GN; Bull JM Cancer Res; 1989 Dec; 49(24 Pt 1):7041-4. PubMed ID: 2582445 [TBL] [Abstract][Full Text] [Related]
44. [Enhancement of hyperthermochemotherapy with hypoxic cell radiosensitizers]. Ohta M; Fujimoto S; Shresta RD; Kokubun M; Kobayashi K; Kiuchi S; Miyoshi T; Arimatsu N; Mori T; Okui K Gan No Rinsho; 1988 Mar; 34(3):283-7. PubMed ID: 3128668 [TBL] [Abstract][Full Text] [Related]
45. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures. Herman TS; Teicher BA; Collins LS Cancer Res; 1988 May; 48(9):2342-7. PubMed ID: 3356002 [TBL] [Abstract][Full Text] [Related]
46. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations. Grdina DJ; Sigdestad CP; Jovonovich JA Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138 [TBL] [Abstract][Full Text] [Related]
47. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide. Milas L; Ito H; Hunter N Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574 [TBL] [Abstract][Full Text] [Related]
48. [The experimental and clinical study of hyperthermia with thermosensitizer for gastric cancer patients with peritoneal seeding]. Kobayashi K; Fujimoto S; Takahashi M; Shrestha RD; Kokubun M; Kiuchi S; Konno C; Nakajima N Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1651-4. PubMed ID: 1530325 [TBL] [Abstract][Full Text] [Related]
49. Modulation of [cis-diaminedichloroplatinum(ii) hyperthermia] therapy by inhibitors of arachidonic-Acid metabolism. Teicher B; Holden S; Herman T; Northey D Int J Oncol; 1994 Jan; 4(1):17-22. PubMed ID: 21566883 [TBL] [Abstract][Full Text] [Related]
50. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole. Siemann DW; Morrissey S; Wolf K Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075 [TBL] [Abstract][Full Text] [Related]
51. Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents. Teicher BA; Holden SA; Ara G; Northey D Anticancer Res; 1993; 13(6A):2101-6. PubMed ID: 7507654 [TBL] [Abstract][Full Text] [Related]
52. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers. Siemann DW Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517 [TBL] [Abstract][Full Text] [Related]
53. Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole. Milas L; Ito H; Nakayama T; Hunter N Cancer Res; 1991 Jul; 51(14):3639-42. PubMed ID: 2065321 [TBL] [Abstract][Full Text] [Related]
54. The effect of prolonged high dose misonidazole on tumor response to radiation. McNally NJ; de Ronde J; Hinchliffe M Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751 [TBL] [Abstract][Full Text] [Related]
55. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics. Wong KH; Maezawa H; Urano M Int J Hyperthermia; 1992; 8(5):645-58. PubMed ID: 1402141 [TBL] [Abstract][Full Text] [Related]
56. The effect of misonidazole in combination with radiation dose fractionation. Hill RP; Bush RS Br J Cancer Suppl; 1978 Jun; 3():255-8. PubMed ID: 277242 [TBL] [Abstract][Full Text] [Related]
57. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo. Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K Oncology; 1996; 53(1):68-72. PubMed ID: 8570136 [TBL] [Abstract][Full Text] [Related]
58. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers. Hinchliffe M; McNally NJ Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081 [TBL] [Abstract][Full Text] [Related]
59. Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor. Teicher BA; Holden SA; Khandakar V; Herman TS J Cancer Res Clin Oncol; 1993; 119(11):645-51. PubMed ID: 8394365 [TBL] [Abstract][Full Text] [Related]
60. [Combined effect of cis-DDP (II), OK-432 and systemic hyperthermia in ascites tumor in mice]. Komatsu K; Nakamura W Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):626-37. PubMed ID: 2504850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]